Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 34

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Change of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73

Bensaad, Karim, Le Bras, Morgane, Unsal, Keziban, Strano, Sabrina, Blandino, Giovanni, Tominaga, Osamu, Rouillard, Dany, Soussi, Thierry · 2003 · Journal of Biological Chemistry

Abstract

Xenopus p53 has biological and biochemical properties similar to those of human p53, except for optimal temperature. The frog protein is fully active at 30 °C and inactive at 37 °C, leading to a temperature-sensitive behavior similar to that of the human mutant p53Ala143 and the murine mutant p53Val135. Using hybrid proteins between human and Xenopus expressed from artificial p53 minigenes, we have been able to demonstrate that change of conformation of the DNA-binding domain is the major determinant of this heat sensitivity. It has been reported that some human tumor-derived p53 mutants can engage in a physical association with p73, thus inhibiting its transactivating properties. The mechanism of this association remains to be elucidated. The nature of the mutant p53 that can engage in this association also remains controversial. Using the unique opportunity of the temperature sensitivity of Xenopus p53, we demonstrate that binding of and interference with p73 require a change of conformation in the p53 protein. This interaction occurs through the DNA-binding domain of p53 only when it is in a denatured state. These results reinforce the notion that mutant p53 with a conformational change can act as a down-regulator of the p73 pathway in human cancer and could confer a selective advantage to the tumor. Xenopus p53 has biological and biochemical properties similar to those of human p53, except for optimal temperature. The frog protein is fully active at 30 °C and inactive at 37 °C, leading to a temperature-sensitive behavior similar to that of the human mutant p53Ala143 and the murine mutant p53Val135. Using hybrid proteins between human and Xenopus expressed from artificial p53 minigenes, we have been able to demonstrate that change of conformation of the DNA-binding domain is the major determinant of this heat sensitivity. It has been reported that some human tumor-derived p53 mutants can engage in a physical association with p73, thus inhibiting its transactivating properties. The mechanism of this association remains to be elucidated. The nature of the mutant p53 that can engage in this association also remains controversial. Using the unique opportunity of the temperature sensitivity of Xenopus p53, we demonstrate that binding of and interference with p73 require a change of conformation in the p53 protein. This interaction occurs through the DNA-binding domain of p53 only when it is in a denatured state. These results reinforce the notion that mutant p53 with a conformational change can act as a down-regulator of the p73 pathway in human cancer and could confer a selective advantage to the tumor. wild type generic term for all members of the 70-kDa heat shock protein family bovine serum albumin Xenopus p53 Human p53 monoclonal antibody phosphate buffer saline The p53 protein plays a crucial role in the cellular response to DNA damage by activating either an apoptotic or a growth-arrest pathway in proliferating cells (1Levine A.J. Cell. 1997; 88: 323-331Abstract Full Text Full Text PDF PubMed Scopus (6740) Google Scholar). Among the various biochemical activities linked to the p53 protein, its main function seems to be its ability to activate transcription from genes containing two contiguous monomers of the (Pu)3xC(A/T)(A/T)G(Py)3x sequence (2El-Deiry W.S. Kern S.E. Pientenpol J.A. Kinzler K.W. Vogelstein B. Nat. Genet. 1992; 1: 45-49Crossref PubMed Scopus (1748) Google Scholar). DNA-binding sites for p53 are localized either in the promoter region or in introns of many target genes involved in either growth arrest or apoptosis (3Zhao R. Gish K. Murphy M. Yin Y. Notterman D. Hoffman W.H. Tom E. Mack D.H. Levine A.J. Genes Dev. 2000; 14: 981-993Crossref PubMed Scopus (275) Google Scholar, 4Yu J. Zhang L. Hwang P.M. Rago C. Kinzler K.W. Vogelstein B. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 14517-14522Crossref PubMed Scopus (416) Google Scholar). The transcription domain of p53 is localized in the amino-terminal part of the protein (residues 1–42), whereas the DNA-binding domain is localized in the central region of the protein (residues 90–290) (5Soussi T. May P. J. Mol. Biol. 1996; 260: 623-637Crossref PubMed Scopus (194) Google Scholar). The importance of this DNA-binding region is emphasized by the observation that more than 14,000 described point mutations of the p53 gene are clustered in this region (6Soussi T. Béroud C. Nat. Rev. Cancer. 2001; 1: 233-240Crossref PubMed Scopus (553) Google Scholar). Many of these mutations are correlated with loss of wild-type (wt)1 p53 function. One important feature of p53 is its flexibility (7Milner J. Trends Biochem. Sci. 1995; 20: 49-51Abstract Full Text PDF PubMed Scopus (92) Google Scholar). The first line of evidence came from work with various monoclonal antibodies. Historically, it was reported that some p53 epitopes either or growth J. PubMed Scopus Google Scholar). It has been that the central region of the p53 protein epitopes that are either of the

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m208233200

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Levine, 1997, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
  2. Zhao, 2000, Genes Dev., 14, 981, 10.1101/gad.827700 · DOI · Paper page
  3. Yu, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 14517, 10.1073/pnas.96.25.14517 · DOI · Paper page
  4. Soussi, 2001, Nat. Rev. Cancer, 1, 233, 10.1038/35106009 · DOI · Paper page
  5. Milner, 1995, Trends Biochem. Sci., 20, 49, 10.1016/S0968-0004(00)88954-9 · DOI
  6. Milner, 1984, Nature, 310, 143, 10.1038/310143a0 · DOI
  7. Gannon, 1990, EMBO J., 9, 1595, 10.1002/j.1460-2075.1990.tb08279.x · DOI · Paper page
  8. Ory, 1994, EMBO J., 13, 3496, 10.1002/j.1460-2075.1994.tb06656.x · DOI · Paper page
  9. Legros, 1994, Oncogene, 9, 3689
  10. Michalovitz, 1990, Cell, 62, 671, 10.1016/0092-8674(90)90113-S · DOI · Paper page
  11. Hainaut, 1995, Br. J. Cancer, 71, 227, 10.1038/bjc.1995.48 · DOI
  12. Hupp, 1992, Cell, 71, 875, 10.1016/0092-8674(92)90562-Q · DOI · Paper page
  13. Hardy-Bessard, 1998, Oncogene, 16, 883, 10.1038/sj.onc.1201598 · DOI
  14. Hupp, 1995, Cell, 83, 237, 10.1016/0092-8674(95)90165-5 · DOI · Paper page
  15. Yang, 1998, Mol. Cell, 2, 305, 10.1016/S1097-2765(00)80275-0 · DOI · Paper page
  16. Kaghad, 1997, Cell, 90, 809, 10.1016/S0092-8674(00)80540-1 · DOI · Paper page
  17. Yang, 2000, Nat. Rev. Mol. Cell. Biol., 1, 199, 10.1038/35043127 · DOI · Paper page
  18. Ikawa, 1999, Cell Death Differ., 6, 1154, 10.1038/sj.cdd.4400631 · DOI
  19. Levrero, 1999, Cell Death Differ., 6, 1146, 10.1038/sj.cdd.4400624 · DOI
  20. Hibi, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 5462, 10.1073/pnas.97.10.5462 · DOI · Paper page
  21. Davison, 1999, J. Biol. Chem., 274, 18709, 10.1074/jbc.274.26.18709 · DOI · Paper page
  22. Gaiddon, 2001, Mol. Cell. Biol., 21, 1874, 10.1128/MCB.21.5.1874-1887.2001 · DOI · Paper page
  23. Strano, 2000, J. Biol. Chem., 275, 29503, 10.1074/jbc.M003360200 · DOI · Paper page
  24. Marin, 2000, Nat. Genet., 25, 47, 10.1038/75586 · DOI · Paper page
  25. Strano, 2002, J. Biol. Chem., 272, 18817, 10.1074/jbc.M201405200 · DOI · Paper page
  26. Yuan, 1999, Nature, 399, 809, 10.1038/21704 · DOI · Paper page
  27. Agami, 1999, Nature, 399, 806, 10.1038/21697 · DOI · Paper page
  28. Jost, 1999, Nature, 399, 814, 10.1038/21710 · DOI
  29. Soussi, 1989, J. Virol., 63, 3894, 10.1128/jvi.63.9.3894-3901.1989 · DOI · Paper page
  30. Wang, 1995, Oncogene, 10, 779
  31. Burge, 1997, J. Mol. Biol., 268, 78, 10.1006/jmbi.1997.0951 · DOI · Paper page
  32. Le Bras, 2002, Oncogene, 21, 1304, 10.1038/sj.onc.1205189 · DOI
  33. Ko, 1996, Genes Dev., 10, 1054, 10.1101/gad.10.9.1054 · DOI · Paper page
  34. Hansen, 1996, J. Biol. Chem., 271, 3917, 10.1074/jbc.271.7.3917 · DOI
  35. Milner, 1991, Cell, 65, 765, 10.1016/0092-8674(91)90384-B · DOI · Paper page
  36. Bullock, 2000, Oncogene, 19, 1245, 10.1038/sj.onc.1203434 · DOI · Paper page
  37. Flores, 2002, Nature, 416, 560, 10.1038/416560a · DOI · Paper page
  38. DiComo, 1999, Mol. Cell. Biol., 19, 1438, 10.1128/MCB.19.2.1438 · DOI · Paper page
  39. Waddell, 2001, Oncogene, 20, 6001, 10.1038/sj.onc.1204702 · DOI
  40. Zhang, 1994, EMBO J., 13, 2535, 10.1002/j.1460-2075.1994.tb06543.x · DOI
  41. Gu, 2000, Mol. Cell. Biol., 20, 1243, 10.1128/MCB.20.4.1243-1253.2000 · DOI

Cited by

See all 34

Metadata

Authors
Bensaad, K., Le Bras, M., Unsal, K., Strano, S., Blandino, G., Tominaga, O., Rouillard, D., & Soussi, T.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2003-03
Volume
278
Issue
12
Pages
10546-10555
ISSN
0021-9258
Cited by
34
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.